Belgium· BE-AMP-SAM552382-00

Spravato 28 mg

A esketamine product containing esketamine hydrochloride, registered in Belgium by Janssen-Cilag International. The same ATC class is registered in 11 of our 19 countries.

ATC N06AX27

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about esketamine hydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Esketamine is registered in 11 of 19 countries.

Countries holding a registration under ATC N06AX27 (esketamine), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
7 of them publish a price we can compare per daily dose

Search esketamine products by name

Esketamine · ATC N06AX27

11 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of esketamine costs, country by country.

Normalised to the WHO defined daily dose (8 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Esketamine · price per daily dose (8 mg)

USD · FX 28 Sept 2026

CH Switzerland$66.47

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Esketamine Hydrochloride
Manufacturer: Janssen-Cilag International
Country: Belgium (BE)
ATC code: N06AX27
ATC class: Esketamine
Defined daily dose: 8 mg, N
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 2

be_apb
7730435
be_apb
4169728

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

91 interactions on record for esketamine.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check esketamine against other medicines How interaction checks work

Esketamine · interactions on record

91 records

7 severe
84 moderate

Most severe, free to view

PhentermineA08AA01severe
FenfluramineA08AA02severe
MazindolA08AA05severe
FenfluramineN03AX26severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Esketamine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All esketamine products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

Austria · Escetex, Eskelan
Germany · Esketamin, Esketamin Inresa
Denmark · Esketamine Orifarm, S-Ketamin Pfizer
Estonia · Esketex
Finland · Esketamine Kalceks, Esketamine Orifarm
France · Eskesia, Esketamine Renaudin
United Kingdom (Northern Ireland) · Esketamine Idd, Esketamine Kalceks
Croatia · Esgamda
Iceland · S-Ketamin Pfizer, Spravato
Liechtenstein · Spravato
Luxembourg · Vesierra
Latvia · Esketamine Kalceks
Netherlands · Esketamine Focus, Esketamine Idd
Norway · Ketanest, Sinmelan
Sweden · Esketamine Kalceks, Esketamine Orifarm
Slovenia · Esketamin Kalceks, Sinmelan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/c9703701-23c4-4b50-9b79-6dd7ef8fc1a6
GET /v1/drugs/c9703701-23c4-4b50-9b79-6dd7ef8fc1a6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Nasal spray, solution",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Spravato 28 mg",
  "name_fr": "Spravato 28 mg",
  "name_nl": "Spravato 28 mg",
  "amp_code": "SAM552382-00",
  "strengths": [
    "140.0000",
    "140.0000",
    "140.0000"
  ],
  "pack_count": 6,
  "substances": [
    "Esketamine Hydrochloride",
    "Esketamine",
    "Disodium Edetate",
    "Sodium Hydroxide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Esketamine",
  "authorisation_numbers": [
    "EU/1/19/1410/002",
    "EU/1/19/1410/003",
    "EU/1/19/1410/001",
    "EU/1/19/1410/004",
    "EU/1/19/1410/005",
    "EU/1/19/1410/006"
  ]
}

API reference MCP server Plans

See everything about esketamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console